• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.

作者信息

Kono M, Yasuda S, Kono M, Atsumi T

机构信息

a Division of Rheumatology, Endocrinology and Nephrology , Hokkaido University Graduate School of Medicine , Sapporo , Japan.

出版信息

Scand J Rheumatol. 2018 May;47(3):248-250. doi: 10.1080/03009742.2017.1297482. Epub 2017 May 8.

DOI:10.1080/03009742.2017.1297482
PMID:28480784
Abstract
摘要

相似文献

1
Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.托珠单抗降低了两名重叠性系统性硬化症和类风湿关节炎患者体内系统性硬化症相关自身抗体及抗环瓜氨酸化蛋白抗体的产生。
Scand J Rheumatol. 2018 May;47(3):248-250. doi: 10.1080/03009742.2017.1297482. Epub 2017 May 8.
2
Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?系统性硬化症与类风湿关节炎的重叠：一种独特的临床实体？
Rev Bras Reumatol Engl Ed. 2016 Jul-Aug;56(4):287-98. doi: 10.1016/j.rbre.2014.12.011. Epub 2015 Jul 13.
3
Pathogenic effects of anti-citrullinated protein antibodies in rheumatoid arthritis - role for glycosylation.抗瓜氨酸化蛋白抗体在类风湿关节炎中的致病作用 - 糖基化的作用。
Joint Bone Spine. 2019 Oct;86(5):562-567. doi: 10.1016/j.jbspin.2019.01.005. Epub 2019 Jan 25.
4
Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study.托珠单抗治疗类风湿关节炎患者的抗环瓜氨酸肽抗体滴度下降：一项初步研究。
Mod Rheumatol. 2020 Mar;30(2):276-281. doi: 10.1080/14397595.2019.1583784. Epub 2019 Mar 21.
5
Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients.托珠单抗治疗系统性硬化症的真实世界经验：对抗拓扑异构酶阳性患者肺功能的潜在益处。
Rheumatology (Oxford). 2021 Aug 2;60(8):3945-3946. doi: 10.1093/rheumatology/keab273.
6
A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.使用第三代抗环瓜氨酸肽检测法（CCP3）对系统性硬化症、原发性胆汁性肝硬化和类风湿关节炎中抗环瓜氨酸肽抗体频率进行比较。
Clin Rheumatol. 2008 Jan;27(1):77-83. doi: 10.1007/s10067-007-0656-4. Epub 2007 Jun 15.
7
A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?1例托珠单抗成功治疗重叠综合征：难治性皮肌炎的一种有希望的治疗策略？
Rheumatology (Oxford). 2014 Oct;53(10):1907-8. doi: 10.1093/rheumatology/keu234. Epub 2014 May 23.
8
Anti-cyclic citrullinated peptide antibody in systemic sclerosis.系统性硬化症中的抗环瓜氨酸肽抗体
Clin Exp Rheumatol. 2008 Jul-Aug;26(4):542-7.
9
Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.类风湿性和非类风湿性风湿性疾病中的抗环瓜氨酸肽抗体：1162例患者的经验
J Rheumatol. 2014 Dec;41(12):2395-402. doi: 10.3899/jrheum.131375. Epub 2014 Oct 1.
10
Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.一名具有多关节炎和硬皮病重叠特征的患者在使用阿达木单抗治疗后出现严重多发性肌炎和自身免疫性发作。
Scand J Rheumatol. 2007 Nov-Dec;36(6):484-6. doi: 10.1080/03009740701281293.

引用本文的文献

1
Systemic sclerosis and rheumatoid arthritis overlap syndrome - management of severe cardiac, pulmonary and articular involvement.系统性硬化症与类风湿关节炎重叠综合征——严重心脏、肺部及关节受累的管理
Reumatologia. 2023;61(1):55-62. doi: 10.5114/reum/161299. Epub 2023 Mar 8.
2
Therapeutic Options for Systemic Sclerosis: Current and Future Perspectives in Tackling Immune-Mediated Fibrosis.系统性硬化症的治疗选择：应对免疫介导性纤维化的现状与未来展望
Biomedicines. 2022 Jan 29;10(2):316. doi: 10.3390/biomedicines10020316.
3
Is biological therapy in systemic sclerosis the answer?
生物疗法是系统性硬化症的答案吗？
Rheumatol Int. 2020 May;40(5):679-694. doi: 10.1007/s00296-020-04515-6. Epub 2020 Jan 20.
4
Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature.皮下注射托珠单抗治疗类风湿关节炎和系统性硬化症重叠综合征患者的疗效：两例报告及文献复习
BMC Rheumatol. 2019 Apr 24;3:15. doi: 10.1186/s41927-019-0063-x. eCollection 2019.